Medication info

Y2ATRACEMI Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Sungy Bio Pharmaceutical Co., Ltd.
Appearance
Light yellow rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202107077 · Approved 2021.10.22

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly Administer the usual adult dose. However, because the elimination half-life of tramadol increases by 17% when tramadol is administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older and adults: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken per day.

Ingredients

Manufacturer
Sungy Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly Administer the usual adult dose. However, because the elimination half-life of tramadol increases by 17% when tramadol is administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older and adults: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken per day.

Precautions

This medication can cause liver damage, so individuals who consume more than 3 alcoholic beverages daily should consult with a physician or pharmacist before taking it. If any abnormal symptoms such as skin rashes or allergic reactions occur while taking this medication, discontinue use immediately and inform healthcare personnel. Dosage should be adhered to within the recommended range, as overdose may increase the risk of seizures. Particular caution is necessary when used in conjunction with other medications that may increase the risk of seizures. Patients with severe respiratory diseases should be administered this medication under the supervision of healthcare personnel, as it may suppress breathing. Taking this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, or coma; therefore, concomitant use should be avoided. Patients with head injuries or increased intracranial pressure should exercise caution, as symptoms may worsen while taking this medication. This medication may cause psychological and physical dependence; careful monitoring for dependence is required during long-term use. Patients with compromised liver function or liver disease must consult a physician before taking this medication due to the risk of hepatotoxicity. Patients with specific genotypes may experience accelerated metabolism of this medication, increasing the risk of respiratory depression; caution is advised. This medication should not be given to children under 12 years of age or adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Patients with sleep apnea or hypoxia should be regularly evaluated for their condition, as symptoms may worsen while taking this medication. Elderly patients or those at risk of hyponatremia should monitor their serum sodium levels while taking this medication. Overdose may lead to severe side effects such as respiratory depression, seizures, and liver damage, requiring immediate emergency treatment. This medication may cause drowsiness or dizziness while driving or operating machinery, necessitating caution. Pregnant or nursing women should consult a physician before taking this medication, and it is safest to avoid it while breastfeeding. This medication interacts with several other drugs; if taking other medications, it is crucial to inform healthcare personnel. Keep out of reach of children and prevent misuse or accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory decrease, tremors, paresthesia, attention disorders, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, fatigue, withdrawal syndrome from medication, thirst, irritability, heat sensations, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal thoughts, muscular hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disorders, prolonged prothrombin time, fixed rash, asthenia, fever, edema, rigidity, fainting, congestive heart failure, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, increased urination, renal function abnormality, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, decreased platelets, arrhythmia, worsening hypertension, aortic stenosis, bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nosebleeds, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, confusion, dyspnea, disorientation, multiple organ failure, intentional overdose, belching, chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress and is best kept at room temperature between 1°C and 30°C. This helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Light yellow rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.